Skip to main content

FDA Updates

FDA Updates

A Dynamic FDA Has Led to More Rapid Cancer Drug Development

Leukemia, FDA Updates

Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation

FDA Updates

Actemra First FDA-Approved Treatment for CAR T-Cell–Induced Severe Cytokine Release Syndrome

FDA Updates

Mylotarg Now Approved for the Treatment of Patients with CD33-Positive AML

FDA Updates

Nivolumab Receives New Indication for dMMR and MSI-H Metastatic Colorectal Cancer

FDA Updates

Besponsa a New Treatment Option for Patients with Relapsed/Refractory B-Cell ALL

FDA Updates

Kymriah First Gene Therapy Approved by the FDA, Indicated for Young Patients with B-Cell ALL and CD19

FDA Updates

FDA News - September 2017

FDA Updates

FDA News - August 2017

FDA Updates

FDA News - June 2017

5
6
7
8
9
10
11

Page 8 of 13
Results 71 - 80 of 123